SBC Medical Group Holdings Incorporated
SBCNASDAQIndustrials● Active
$3.02
+$0.01(+0.33%)
Market Cap$310597789
P/E Ratio—
52W High$5.75
52W Low$2.78
SBC Medical Group Holdings Incorporated (SBC) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
SBC · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 14, 2026EPS Actual
$0.11
Est. $0.10 · +10.0%
Revenue
$0.04B
Est. $0.04B · +3.4%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 14, 2026
After Market Close
▲ Beat EPS▲ Beat Revenue✓ 2-Quarter EPS Beat Streak
SBC reports quarterly as a NASDAQ-listed Consulting Services company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.07
Rev. $15.39B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.07
Rev. Est.$15.39B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 12, 2026 | $0.12 | — | — | — | $0.05B | — |
| ▲ Q2 FY2026 | May 14, 2026 | $0.10 | $0.11 | +10.0% | $0.04B | $0.04B | +3.4% |
| ▲ Q1 FY2026 | Mar 27, 2026 | $0.13 | $0.14 | +7.7% | $0.04B | $0.05B | -12.9% |
| ▼ Q4 FY2025 | Nov 14, 2025 | $0.13 | $0.12 | -7.7% | $0.04B | $0.05B | -4.1% |
| ▼ Q3 FY2025 | Aug 13, 2025 | $0.14 | $0.02 | -85.7% | $0.04B | $0.05B | -5.0% |
| ▲ Q2 FY2025 | May 15, 2025 | $0.11 | $0.21 | +90.9% | $0.05B | $0.04B | +5.8% |
| ▲ Q1 FY2025 | Mar 28, 2025 | $0.17 | $0.18 | +5.9% | $0.04B | $0.06B | -21.9% |
| ▼ Q4 FY2024 | Nov 13, 2024 | $0.19 | $0.03 | -84.2% | $0.05B | $0.06B | -5.8% |
Q3 FY2026
Aug 12, 2026
EPS Actual
—
EPS Est.
$0.12
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 14, 2026Beat
EPS Actual
$0.11
EPS Est.
$0.10
EPS Surpr.
+10.0%
Revenue
$0.04B
Q1 FY2026
Mar 27, 2026Beat
EPS Actual
$0.14
EPS Est.
$0.13
EPS Surpr.
+7.7%
Revenue
$0.04B
Q4 FY2025
Nov 14, 2025Miss
EPS Actual
$0.12
EPS Est.
$0.13
EPS Surpr.
-7.7%
Revenue
$0.04B
Q3 FY2025
Aug 13, 2025Miss
EPS Actual
$0.02
EPS Est.
$0.14
EPS Surpr.
-85.7%
Revenue
$0.04B
Q2 FY2025
May 15, 2025Beat
EPS Actual
$0.21
EPS Est.
$0.11
EPS Surpr.
+90.9%
Revenue
$0.05B
Q1 FY2025
Mar 28, 2025Beat
EPS Actual
$0.18
EPS Est.
$0.17
EPS Surpr.
+5.9%
Revenue
$0.04B
Q4 FY2024
Nov 13, 2024Miss
EPS Actual
$0.03
EPS Est.
$0.19
EPS Surpr.
-84.2%
Revenue
$0.05B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.13 | $0.14 | $0.14 | 1 |
| Q3 FY2028 | $0.12 | $0.12 | $0.13 | 1 |
| Q2 FY2028 | $0.12 | $0.13 | $0.13 | 1 |
| Q1 FY2028 | $0.11 | $0.11 | $0.11 | 1 |
| Q4 FY2027 | $0.12 | $0.13 | $0.13 | 1 |
| Q3 FY2027 | $0.11 | $0.12 | $0.12 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.1B | $0.1B | $0.1B | 1 |
| Q3 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2028 | $0.0B | $0.0B | $0.1B | 1 |
| Q1 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2027 | $0.0B | $0.1B | $0.1B | 1 |
| Q3 FY2027 | $0.0B | $0.0B | $0.0B | 2 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 14, 2026 | +10.0% | $3.23 | $2.98 | -7.74% |
| ▲ Q1 FY2026 | Mar 27, 2026 | +7.7% | $3.80 | $3.96 | +4.21% |
| ▼ Q4 FY2025 | Nov 14, 2025 | -7.7% | $3.36 | $3.31 | -1.49% |
| ▼ Q3 FY2025 | Aug 13, 2025 | -85.7% | $4.54 | $4.32 | -4.85% |
| ▲ Q2 FY2025 | May 15, 2025 | +90.9% | $3.36 | $3.48 | +3.57% |
| ▲ Q1 FY2025 | Mar 28, 2025 | +5.9% | $3.75 | $3.28 | -12.53% |
| ▼ Q4 FY2024 | Nov 13, 2024 | -84.2% | $6.96 | $6.96 | +0.00% |
| — Q2 FY2024 | Jun 30, 2024 | — | $13.07 | $13.07 | +0.00% |
Q2 FY2026-7.74%
Report Date
May 14, 2026
EPS Beat/Miss
+10.0%
Price Before
$3.23
Price After
$2.98
Q1 FY2026+4.21%
Report Date
Mar 27, 2026
EPS Beat/Miss
+7.7%
Price Before
$3.80
Price After
$3.96
Q4 FY2025-1.49%
Report Date
Nov 14, 2025
EPS Beat/Miss
-7.7%
Price Before
$3.36
Price After
$3.31
Q3 FY2025-4.85%
Report Date
Aug 13, 2025
EPS Beat/Miss
-85.7%
Price Before
$4.54
Price After
$4.32
Q2 FY2025+3.57%
Report Date
May 15, 2025
EPS Beat/Miss
+90.9%
Price Before
$3.36
Price After
$3.48
Q1 FY2025-12.53%
Report Date
Mar 28, 2025
EPS Beat/Miss
+5.9%
Price Before
$3.75
Price After
$3.28
Q4 FY2024+0.00%
Report Date
Nov 13, 2024
EPS Beat/Miss
-84.2%
Price Before
$6.96
Price After
$6.96
Q2 FY2024+0.00%
Report Date
Jun 30, 2024
EPS Beat/Miss
—
Price Before
$13.07
Price After
$13.07
Avg Beat Reaction-3.12%
Avg Miss Reaction-2.11%
Beat Rate4 / 8 quarters
Largest Move-12.53% (Q1 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: SBC ends December
SBC Medical Group Holdings Incorporated (SBC) most recently reported earnings on May 14, 2026 for Q2 FY2026, posting EPS of $0.11 — beating the analyst consensus of $0.10 by +10.0%. SBC has beaten EPS estimates for 2 consecutive quarters. The next SBC earnings date is expected around September 1, 2026.
Each quarter, investors track SBC earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. SBC revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
SBC's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
SBC earnings · 5 questionsSBC Medical Group Holdings Incorporated's next earnings report is expected around September 1, 2026. SBC typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; SBC historically reports after market close (AMC).
SBC earnings datewhen is SBC earningsSBC next earnings datewhen does SBC report earningsSBC earnings calendar
▸ Source: FMP · SBC Medical Group Holdings Incorporated SEC filings · US GAAP · SBC Medical Group Holdings Incorporated SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026